Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Class A Ordinary Shares
-
Shares outstanding
-
73,666,602
-
Total 13F shares
-
44,873,374
-
Share change
-
+3,620,614
-
Total reported value
-
$235,135,504
-
Put/Call ratio
-
3439%
-
Price per share
-
$5.24
-
Number of holders
-
74
-
Value change
-
+$20,751,444
-
Number of buys
-
44
-
Number of sells
-
31
Institutional Holders of Zura Bio Ltd - Class A Ordinary Shares (ZURA) as of Q4 2025
As of 31 Dec 2025,
Zura Bio Ltd - Class A Ordinary Shares (ZURA) was held by
74 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
44,873,374 shares.
The largest 10 holders included
SUVRETTA CAPITAL MANAGEMENT, LLC, VR ADVISER, LLC, JPMORGAN CHASE & CO, GREAT POINT PARTNERS LLC, BRAIDWELL LP, Pfizer Inc, ADAGE CAPITAL PARTNERS GP, L.L.C., Affinity Asset Advisors, LLC, ARMISTICE CAPITAL, LLC, and MORGAN STANLEY.
This page lists
74
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.